33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A single center retrospective evaluation of daratumumab infusion related reactions with split-first dose day 1 and day 2 infusion
    Meeting Abstract

    McBride, A.; Usman, M.; Khalil, M. J.; Tariq, M. J.; Fraz, M. A.; Ijaz, A.; Ahmad, M. Q.; Khan, A. Y.; Samuel, S.; Selene, I. I.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Survival analysis from the CALGB study of lenalidomide maintenance therapy in newly diagnosed multiple myeloma post-autologous stem cell transplantation adjusted for crossover (Alliance 100104)
    Meeting Abstract

    McCarthy, P. L.; Richardson, P.; Suman, V.; Cooper, M.; Saunders, O.; Dhanasiri, S.; Giralt, S.; Anderson, K.; Stadtmauer, E.; Holstein, S. A.
    Blood (2018)

    Fulltext@MSK | Save
  • Updated report on identification of molecular predictors of tazemetostat response in an ongoing NHL phase 2 study
    Meeting Abstract

    McDonald, A.; Thomas, E.; Daigle, S.; Morschhauser, F.; Salles, G.; Ribrag, V.; McKay, P.; Tilly, H.; Schmitt, A.; Batlevi, C. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Impact on MPN symptoms and quality of life of front line pegylated interferon alpha-2a vs. hydroxyurea in high risk polycythemia vera and essential thrombocythemia: Results of myeloproliferative disorders research consortium (MPD-RC) 112 global phase III trial
    Meeting Abstract

    Mesa, R. A.; Kosiorek, H. E.; Mascarenhas, J.; Prchal, J. T.; Rambaldi, A.; Berenzon, D.; Yacoub, A.; Harrison, C. N.; McMullin, M. F.; Vannucchi, A. M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Cardiovascular hospitalization in patients treated with dasatinib or nilotinib in SIMPLICITY, an observational study of chronic-phase chronic myeloid leukemia (CP-CML) patients in routine clinical practice
    Meeting Abstract

    Mauro, M. J.; Chen, C.; Cortes, J. E.; Gambacorti-Passerini, C.; Sen, G. P.; Gajavelli, S.; Davis, C.; Michallet, M.
    Blood (2018)

    Fulltext@MSK | Save
  • Venetoclax as monotherapy or in combination: Patterns of use and predictors of outcomes in an international multicenter study of CLL patients
    Meeting Abstract

    Mato, A. R.; Roeker, L. E.; Eyre, T. A.; Nabhan, C.; Lamanna, N.; Hill, B. T.; Brander, D. M.; Barr, P.; Lansigan, F.; Cheson, B.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic testing and treatment approaches in patients with chronic lymphocytic leukemia: Clinical experience from an interim analysis of the informCLL (TM) real-world registry
    Meeting Abstract

    Mato, A. R.; Barrientos, J. C.; Brander, D. M.; Pagel, J. M.; Gutierrez, M.; Kadish, K.; Tomlinson, B.; Ghosh, N.; Giafis, N.; Ipe, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Evaluation of cord blood (CB) unit TNC & CD34+ cell content & donor-recipient high-resolution 8 HLA-allele match by patient ancestry: An evaluation of 513 CB units in a racially & ethnically diverse population of adults with hematologic malignancies
    Meeting Abstract

    Mazis, C.; Politikos, I.; Devlin, S. M.; Maloy, M.; Davis, E.; Cooper, C.; Nhaissi, M.; Suri, B.; Wells, D.; Giralt, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A phase I, open-label study to evaluate the safety, pharmacokinetic, pharmacodynamic, and clinical activity of PF-06863135, a B-cell maturation antigen/CD3 bispecific antibody, in patients with relapsed/refractory advanced multiple myeloma
    Meeting Abstract

    Lesokhin, A. M.; Raje, N.; Gasparetto, C. J.; Walker, J.; Krupka, H. I.; Joh, T.; Taylor, C. T.; Jakubowiak, A.
    Blood (2018)

    Fulltext@MSK | Save
  • Allogeneic stem cell transplantation overcomes the negative prognostic impact of TP53 alterations in mantle cell lymphoma
    Meeting Abstract

    Lin, R. J.; Ho, C.; Hilden, P.; Barker, J.; Giralt, S.; Hamlin, P. A.; Jakubowski, A. A.; Castro-Malaspina, H. R.; Papadopoulos, E. B.; Perales, M. A.; more...
    Blood (2018)

    Fulltext@MSK | Save